Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common HIV drug be repurposed as an anal cream?

NCT ID NCT05334004

First seen Feb 11, 2026 · Last updated Jun 18, 2026 · Updated 17 times

Summary

This early-stage study tests whether a cream made from two HIV drugs (lopinavir/ritonavir) can be safely placed inside the anus to treat high-grade anal growths (AIN 2/3) in people living with HIV. About 21 participants will receive the cream for a few months and be followed for 40 weeks. The main goal is to find a safe dose, but researchers will also check if the growths shrink or disappear.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-GRADE ANAL INTRAEPITHELIAL NEOPLASIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UW Digestive Health Center Anoscopy Clinic

    RECRUITING

    Madison, Wisconsin, 53705, United States

Conditions

The condition(s) this trial relates to.

anal canal carcinoma in situ squamous cell intraepithelial neoplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.